Cargando…
Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176389/ https://www.ncbi.nlm.nih.gov/pubmed/36604153 http://dx.doi.org/10.1136/ard-2022-223562 |
| _version_ | 1785040423966736384 |
|---|---|
| author | Zhang, Le Li, Jun Yin, Hanlin Chen, Dandan Li, Yuan Gu, Liyang Fu, Yakai Chen, Jie Chen, Zhiwei Yang, Shaoying Ye, Shuang Li, Ting Lu, Liangjing |
| author_facet | Zhang, Le Li, Jun Yin, Hanlin Chen, Dandan Li, Yuan Gu, Liyang Fu, Yakai Chen, Jie Chen, Zhiwei Yang, Shaoying Ye, Shuang Li, Ting Lu, Liangjing |
| author_sort | Zhang, Le |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10176389 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101763892023-05-13 Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study Zhang, Le Li, Jun Yin, Hanlin Chen, Dandan Li, Yuan Gu, Liyang Fu, Yakai Chen, Jie Chen, Zhiwei Yang, Shaoying Ye, Shuang Li, Ting Lu, Liangjing Ann Rheum Dis Letter BMJ Publishing Group 2023-05 2023-01-05 /pmc/articles/PMC10176389/ /pubmed/36604153 http://dx.doi.org/10.1136/ard-2022-223562 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter Zhang, Le Li, Jun Yin, Hanlin Chen, Dandan Li, Yuan Gu, Liyang Fu, Yakai Chen, Jie Chen, Zhiwei Yang, Shaoying Ye, Shuang Li, Ting Lu, Liangjing Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title | Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title_full | Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title_fullStr | Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title_full_unstemmed | Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title_short | Efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| title_sort | efficacy and safety of tofacitinib in patients with polymyalgia rheumatica: a phase 2 study |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176389/ https://www.ncbi.nlm.nih.gov/pubmed/36604153 http://dx.doi.org/10.1136/ard-2022-223562 |
| work_keys_str_mv | AT zhangle efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT lijun efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT yinhanlin efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT chendandan efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT liyuan efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT guliyang efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT fuyakai efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT chenjie efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT chenzhiwei efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT yangshaoying efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT yeshuang efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT liting efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study AT luliangjing efficacyandsafetyoftofacitinibinpatientswithpolymyalgiarheumaticaaphase2study |